ZURICH (Reuters) -Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian...

By Mimosa Spencer PARIS (Reuters) - Shares of Kering are expected to open down on Wednesday, after the company warned first quarter sales at its star label Gucci would drop by around 20% due to weakness in Asia. The warning underscores the challenge Kering faces as it seeks to reignite sales momentum at Gucci, which accounts for half of group...

SINGAPORE (Reuters) -Oil prices edged lower on Wednesday, as a stronger dollar curbed investor appetite while traders took some money off the table after benchmarks rallied to multi-month highs in the previous session. Brent crude futures for May fell 28 cents, or 0.3%, to $87.10 a barrel by 0711 GMT. U.S. West Texas Intermediate futures for April delivery, which expire...

ZURICH, March 20 (Reuters) - Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash. Lonza plans to invest around 500 million Swiss francs ($562.3 million) to upgrade the facility and enhance capabilities at the site to accommodate the next...